{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T19:08:00Z","timestamp":1795115280155,"version":"4.10.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40257-015-0169-x","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T04:24:26Z","timestamp":1451449466000},"page":"87-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey"],"prefix":"10.1007","volume":"17","author":[{"given":"Mark G.","family":"Lebwohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby S.","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"169_CR1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","volume":"70","author":"TD Rachakonda","year":"2014","unstructured":"Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"169_CR2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","volume":"60","author":"SK Kurd","year":"2009","unstructured":"Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003\u20132004. J Am Acad Dermatol. 2009;60:218\u201324.","journal-title":"J Am Acad Dermatol"},{"key":"169_CR3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaad.2008.10.062","volume":"60","author":"M Icen","year":"2009","unstructured":"Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60:394\u2013401.","journal-title":"J Am Acad Dermatol"},{"key":"169_CR4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2011-200387","volume":"71","author":"V Strand","year":"2012","unstructured":"Strand V, Sharp V, Koenig AS, et al. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Ann Rheum Dis. 2012;71:1143\u201350.","journal-title":"Ann Rheum Dis"},{"key":"169_CR5","doi-asserted-by":"crossref","first-page":"e52935","DOI":"10.1371\/journal.pone.0052935","volume":"7","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003\u20132011. PLoS One. 2012;7:e52935.","journal-title":"PLoS One"},{"key":"169_CR6","first-page":"1146","volume":"5","author":"A Darjani","year":"2014","unstructured":"Darjani A, Heidarzadeh A, Golchai J, et al. Quality of life in psoriatic patients: a study using the Short Form-36. Int J Prev Med. 2014;5:1146\u201352.","journal-title":"Int J Prev Med"},{"key":"169_CR7","doi-asserted-by":"crossref","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64(Suppl 2):ii14\u2013ii17.","DOI":"10.1136\/ard.2004.032482"},{"key":"169_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40257-013-0032-x","volume":"14","author":"WH Boehncke","year":"2013","unstructured":"Boehncke WH, Menter A. Burden of disease: psoriasis and psoriatic arthritis. Am J Clin Dermatol. 2013;14:377\u201388.","journal-title":"Am J Clin Dermatol"},{"key":"169_CR9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol. 2013;69:729\u201335.","journal-title":"J Am Acad Dermatol"},{"key":"169_CR10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3899\/jrheum.090988","volume":"37","author":"TY Zhu","year":"2010","unstructured":"Zhu TY, Tam LS, Leung YY, et al. Socioeconomic burden of psoriatic arthritis in Hong\u00a0Kong: direct and indirect costs and the influence of disease pattern. J Rheumatol. 2010;37:1214\u201320.","journal-title":"J Rheumatol"},{"key":"169_CR11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3899\/jrheum.081015","volume":"36","author":"JA Singh","year":"2009","unstructured":"Singh JA, Strand V. Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol. 2009;36:1012\u201320.","journal-title":"J Rheumatol"},{"key":"169_CR12","unstructured":"American Academy of Dermatology and AAD Association. Position statement for maintenance therapy for psoriasis patients. American Academy of Dermatology and AAD Association. 2012. https:\/\/www.aad.org\/Forms\/Policies\/Uploads\/PS\/PS-Maintenance%20Therapy%20for%20Psoriasis%20Patients.pdf . Accessed 3 Feb 2015."},{"key":"169_CR13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamadermatol.2013.5264","volume":"149","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003\u20132011. JAMA Dermatol. 2013;149:1180\u20135.","journal-title":"JAMA Dermatol"},{"key":"169_CR14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","volume":"70","author":"MG Lebwohl","year":"2014","unstructured":"Lebwohl MG, Bachelez H, Barker J, et al. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey. J Am Acad Dermatol. 2014;70:871\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"169_CR15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/247553031420a00404","volume":"20","author":"MG Lebwohl","year":"2014","unstructured":"Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS, Kalb RE. Patient perspectives on psoriasis management: US results of the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey. Psoriasis Forum. 2014;20:124\u201331.","journal-title":"Psoriasis Forum"},{"key":"169_CR16","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/jdv.13150","volume":"29","author":"PCM Kerkhof van de","year":"2015","unstructured":"van de Kerkhof PCM, Reich K, Kavanaugh A, et al. Physician perspectives in the managment of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey. J Eur Acad Dermatol Venereol. 2015;29:2002\u201310.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"169_CR17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamadermatol.2013.133","volume":"149","author":"T Bhutani","year":"2013","unstructured":"Bhutani T, Wong JW, Bebo BF, Armstrong AW. Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels. JAMA Dermatol. 2013;149:717\u201321.","journal-title":"JAMA Dermatol"},{"key":"169_CR18","doi-asserted-by":"crossref","unstructured":"Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis 2005;64(Suppl 2):ii65\u2013ii68.","DOI":"10.1136\/ard.2004.031237"},{"issue":"Suppl 5","key":"169_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.12560","volume":"28","author":"MA Richard","year":"2014","unstructured":"Richard MA, Barnetche T, Rouzaud M, et al. Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion. J Eur Acad Dermatol Venereol. 2014;28(Suppl 5):3\u201312.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"169_CR20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","volume":"58","author":"A Menter","year":"2008","unstructured":"Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section\u00a01. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"169_CR21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaad.2008.02.040","volume":"58","author":"A Gottlieb","year":"2008","unstructured":"Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section\u00a02. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851\u201364.","journal-title":"J Am Acad Dermatol"},{"key":"169_CR22","doi-asserted-by":"crossref","unstructured":"Yeung H, Wan J, Van Voorhees AS et al. Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol. 2013;68:64\u201372.","DOI":"10.1016\/j.jaad.2012.06.035"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-015-0169-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0169-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T22:10:18Z","timestamp":1567462218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-015-0169-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1007\/s40257-015-0169-x","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]}}}